Results for sanofi-aventis: 35

Sanofi-Aventis, the fourth-largest pharmaceutical company by prescription sales, Saturday signed a letter of intent with China's Minsheng Pharmaceutical Group on setting up a joint venture that focuses on vitamin and mineral medicines. The new JV will be a strategic platform for Sanofi-Aventis to enter the Chinese...

Sanofi-Aventis, Europe's leading drug producer and the fourth-largest in the world, will invest US$90 million to expand its Beijing plant, which produces Lantus, a form of insulin, the company said in a statement on Tuesday.The new production line is expected to start operation in 2012 and reach a...

Merial, the animal health unit of Sanofi-Aventis SA, said on Monday that Merial Animal Health Co (China), the group's first production facility in the Chinese market, has invested US$70 million to expand its facility in Nanchang, Jiangxi Province, sources reported.The expansion project is located in the Nanchang Hi-tech...

Oct. 24, 2008 (China Knowledge) - Sanofi-Aventis SA, the third largest pharmaceutical company in the world, announced that it will boost its R&D presence in China as well as expand its R&D facility in Shanghai.The...

HONG KONG, Oct 13 - French drugmaker Sanofi-Aventis hopes to sell 25 million doses of seasonal flu vaccine annually into China's largely untapped domestic market once its plant in the southern city of Shenzhen goes...

HONG KONG, Oct 13 - French drugmaker Sanofi-Aventis hopes to sell 25 million doses of seasonal flu vaccine annually into China's largely untapped domestic market once its plant in the southern city of Shenzhen goes...

* Prilosec, Nexium cut Plavix effectiveness by nearly half * FDA: Plavix label to highlight interaction risk * Warning follows data from new Sanofi-Aventis study (Recasts first sentence, adds details on new study, comment from...

* Prilosec cuts Plavix effectiveness by nearly half * FDA: Plavix label will highlight interaction risk (Adds details, background) WASHINGTON, Nov 17 - Common heartburn pills like Prilosec interfere with Sanofi-Aventis SA's and Bristol-Myers Squibb...

* CEO says will fight against globalisation of business * Diversification and emerging markets key growth drivers LONDON, Nov 17 - French drugmaker Sanofi-Aventis sees major growth drivers in China and India but its chief...

CAMBRIDGE, Mass., Nov 10 - Production of H1N1 swine flu vaccine at two facilities in Pennsylvania is "working optimally," with output on the rise, the chief executive of Sanofi-Aventis SA said on Tuesday. The giant...